Landscapes / Companies
Kure Cells, INC not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 1 checked
Trials
2 active
2 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
UF-KURE19not checked |
— |
Phase 2 | 31 Aug 2029Phase 2 trial completes | ||
| Next date | 31 Aug 2029 · Phase 2 trial completes | ||||
| Also tested for | Lymphoma Nonhodgkin, Marginal Zone B Cell Lymphoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Sep 2028Phase 1 trial completes | |||
| Next date | 30 Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021